Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05056701

Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia. Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense. The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood. Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.

Conditions

Interventions

TypeNameDescription
OTHERannual follow-up during 10 yearsan annual follow-up is carried out systematically for a total of 10 years in order to detect the subsequent occurrence of CKD

Timeline

Start date
2022-05-30
Primary completion
2037-05-30
Completion
2037-05-30
First posted
2021-09-24
Last updated
2024-09-04

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05056701. Inclusion in this directory is not an endorsement.